Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Sight Sciences, Inc.

NASDAQ: SGHT · Industrial Applications and Services · 7 alerts · CIK 1531177

Share price
$10.59Close, Nov 16
Market cap
$589M
Shares outstanding
55.58MLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Surgical & Medical Instruments & ApparatusSIC 3841

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Sight Sciences, Inc. filings on SEC EDGAR ↗

4:18 PM ET 10-Q
Financial Results

Sight Sciences Q3 2026 Results: Net Loss of $6.81M, Loss Narrows

Sight Sciences, Inc. reported total assets of $104.9 million as of September 30, 2026, a decrease from $115.3 million at the end of 2025, primarily driven by a reduction in cash and cash equivalents. The company continues to focus on its Interventional Glaucoma and Dry Eye products while implementing cost-reduction plans to manage operating expenses and net losses.

Key figure
Net loss $6.81M
4:13 PM ET 8-K
Financial Results

Sight Sciences Financial Results

Sight Sciences reported record third-quarter 2026 revenue of $24.9 million, a 25% increase year-over-year, driven by significant growth in its Interventional Dry Eye segment. The company improved its net loss to $6.8 million and raised its full-year 2026 revenue guidance to a range of $99.1 million to $101.1 million.

“We delivered another strong quarter with 25% total revenue growth, record IDE revenue, continued IG revenue growth, and a significant reduction in cash burn. These results demonstrate increasing adoption of our technologies, disciplined execution across our organization, and our growing impact on patients with glaucoma and dry eye disease.”

Paul Badawi, Co-Founder and CEO of Sight Sciences
4:44 PM ET Form 4
Insider Selling

Sight Sciences EVP, Operations & R&D Brenton Taylor Sells $26.5K of Stock

Brenton Taylor, EVP, Operations & R&D, sold 2,988 shares of Sight Sciences, Inc. at $8.85 a share, worth $26.5K in total on Oct 2, 2026. Shares held after the trade: 261,990 (-1.1%).

Value
$26.5K
Shares
2,988
Price
$8.85
Role
EVP, Operations & R&D
Holding change
-1.1%
Trade date
Oct 2, 2026
4:43 PM ET Form 4
Insider Selling

Sight Sciences COO Alison Bauerlein Sells $224K of Stock

Alison Bauerlein, COO, sold 25,260 shares of Sight Sciences, Inc. at $8.85 a share, worth $224K in total on Oct 2, 2026. Shares held after the trade: 639,449 (-3.8%).

Value
$224K
Shares
25,260
Price
$8.85
Role
COO
Holding change
-3.8%
Trade date
Oct 2, 2026
4:42 PM ET Form 4
Insider Selling

Sight Sciences CFO James Rodberg Sells $63.8K of Stock

James Rodberg, CFO, sold 7,208 shares of Sight Sciences, Inc. at $8.85 a share, worth $63.8K in total on Oct 2, 2026. Shares held after the trade: 216,829 (-3.2%).

Value
$63.8K
Shares
7,208
Price
$8.85
Role
CFO
Holding change
-3.2%
Trade date
Oct 2, 2026
4:41 PM ET Form 4
Insider Selling

Sight Sciences CTO David Badawi Sells $70.6K of Stock

David Badawi, CTO, sold 7,797 shares of Sight Sciences, Inc. at $9.05 a share, worth $70.6K in total on Oct 1, 2026. Shares held after the trade: 1,975,075 (-0.4%).

Value
$70.6K
Shares
7,797
Price
$9.05
Role
CTO
Holding change
-0.4%
Trade date
Oct 1, 2026
4:40 PM ET Form 4
Insider Selling

Sight Sciences President and CEO Paul Badawi Sells $268K of Stock

Paul Badawi, President and CEO, sold 29,653 shares of Sight Sciences, Inc. at $9.05 a share, worth $268K in total on Oct 1, 2026. Shares held after the trade: 6,092,819 (-0.5%).

Value
$268K
Shares
29,653
Price
$9.05
Role
President and CEO
Holding change
-0.5%
Trade date
Oct 1, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.